These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8801064)

  • 1. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury.
    Zalups RK; Barfuss DW
    Drug Metab Dispos; 1996 Apr; 24(4):480-6. PubMed ID: 8801064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal handling of mercury in the rat: implications of intestinal secretion of inorganic mercury following biliary ligation or cannulation.
    Zalups RK
    J Toxicol Environ Health A; 1998 Apr; 53(8):615-36. PubMed ID: 9572160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced renal outer medullary uptake of mercury associated with uninephrectomy: implication of a luminal mechanism.
    Zalups RK
    J Toxicol Environ Health; 1997 Feb; 50(2):173-94. PubMed ID: 9048960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of glutathione in the kidney and the renal disposition of administered inorganic mercury.
    Zalups RK; Lash LH
    Drug Metab Dispos; 1997 Apr; 25(4):516-23. PubMed ID: 9107552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminal and basolateral mechanisms involved in the renal tubular uptake of inorganic mercury.
    Zalups RK; Minor KH
    J Toxicol Environ Health; 1995 Sep; 46(1):73-100. PubMed ID: 7666495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basolateral uptake of mercuric conjugates of N-acetylcysteine and cysteine in the kidney involves the organic anion transport system.
    Zalups RK
    J Toxicol Environ Health A; 1998 Sep; 55(1):13-29. PubMed ID: 9747601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of inorganic mercury following biliary obstruction and chemically induced glutathione depletion: dispositional changes one hour after the intravenous administration of mercuric chloride.
    Zalups RK; Barfuss DW; Lash LH
    Toxicol Appl Pharmacol; 1999 Jan; 154(2):135-44. PubMed ID: 9925797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic anion transport and action of gamma-glutamyl transpeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):289-98. PubMed ID: 7785056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small aliphatic dicarboxylic acids inhibit renal uptake of administered mercury.
    Zalups RK; Barfuss DW
    Toxicol Appl Pharmacol; 1998 Jan; 148(1):183-93. PubMed ID: 9465278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basolateral uptake of inorganic mercury in the kidney.
    Zalups RK
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):192-9. PubMed ID: 9705903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal disposition of mercury in rats after intravenous injection of inorganic mercury and cysteine.
    Zalups RK; Barfuss DW
    J Toxicol Environ Health; 1995 Apr; 44(4):401-13. PubMed ID: 7723073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystine alters the renal and hepatic disposition of inorganic mercury and plasma thiol status.
    Zalups RK; Lash LH
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):88-97. PubMed ID: 16466761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation and handling of inorganic mercury in the kidney after coadministration with glutathione.
    Zalups RK; Barfuss DW
    J Toxicol Environ Health; 1995 Apr; 44(4):385-99. PubMed ID: 7723072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with p-aminohippurate inhibits the renal uptake and accumulation of injected inorganic mercury in the rat.
    Zalups RK; Barfuss DW
    Toxicology; 1995 Nov; 103(1):23-35. PubMed ID: 8525487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous coexposure to inorganic mercury and cadmium: a study of the renal and hepatic disposition of mercury and cadmium.
    Zalups RK; Barfuss DW
    J Toxicol Environ Health A; 2002 Oct; 65(19):1471-90. PubMed ID: 12396877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal distribution of inorganic mercury and albumin after coadministration.
    Zalups RK; Barfuss DW
    J Toxicol Environ Health; 1993 Sep; 40(1):77-103. PubMed ID: 8360944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.